|
Market Closed -
Xetra
11:35:30 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 327.30 EUR | -0.79% |
|
-13.13% | +16.77% |
| 09-11 | Dublin residents have mixed feelings ahead of Trump visit to Ireland | RE |
| 09-10 | Amgen Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-10-2026 11:00 AM |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 126,718 | 140,139 | 154,142 | 140,103 | 176,250 | 204,007 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 15.75% | - | - |
| Enterprise Value (EV) 1 | 151,990 | 169,779 | 207,811 | 188,229 | 221,725 | 245,493 | 239,824 | 234,820 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 10.72% | -2.31% | -2.09% |
| P/E | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 23.9x | 21.3x | 20.6x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 18x | 14.7x | 11.9x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 2.2x | 1.8x | 5.54x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 5.24x | 5.07x | 4.91x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 6.3x | 5.96x | 5.65x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 11.2x | 10.8x | 10.5x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 14.5x | 13.6x | 12.8x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 22.1x | 16.3x | 15.3x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 4.53% | 6.14% | 6.55% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | 9.52 | 10.09 | 10.66 | 11.12 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | 2.91% | 2.67% | 2.82% | 2.95% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 15.81 | 17.68 | 18.34 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | 66.9% | 63.8% | 60.3% | 60.6% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 38,938 | 40,232 | 41,543 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,864 | 22,215 | 22,327 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,964 | 17,664 | 18,357 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 8,691 | 9,363 | 9,994 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 41,485 | 35,816 | 30,812 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 377.35 | 377.35 | 377.35 |
| Nbr of stocks (in thousands) | 563,266 | 533,579 | 535,178 | 537,533 | 538,481 | 540,632 | - | - |
| Announcement Date | 2/7/22 | 1/31/23 | 2/6/24 | 2/4/25 | 2/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.77x | 11.54x | 23.41x | 0.62% | 994B | |
| 29.54x | - | - | 2.02% | 640B | |
| 32.92x | 7.63x | 15.78x | 2.67% | 454B | |
| 18.71x | 4.57x | 11.31x | 2.91% | 337B | |
| 19.41x | 5.08x | 12.59x | 3.23% | 261B | |
| 20.34x | 4.19x | 11.96x | 2.11% | 246B | |
| 23.87x | 6.3x | 11.23x | 2.67% | 204B | |
| 12.3x | 4.48x | 9.37x | 4.08% | 190B | |
| -43.47x | 6.35x | 24.81x | 2.29% | 178B | |
| Average | 16.16x | 6.27x | 15.06x | 2.51% | 389.42B | |
| Weighted average by Cap. | 23.19x | 7.72x | 17.10x | 2.05% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
- Valuation Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
